INS and metabolic syndrome: Studies focusing on the administration of beneficial microbes to diabetes-prone or MetS individuals have reported increased insulin sensitivity and reduced weight gain (Rajkumar et al., 2014; Stenman et al., 2014; Hulston et al., 2015).